We demonstrated previously that inflammatory cytokines TNFα, IL1β, IL6 and IL8 are significantly expressed in meconium-instilled lungs. Captopril was a strong inhibitor of meconium-induced lung injury, inflammation and apoptosis and reduces lung alveolar and airway epithelial cell damage. Presently we demonstrate that IL13 expression in the meconium aspiration syndrome (MAS). IL13 was maximally expressed 8 hrs after meconium instillation. It was previously described that IL13 plays a major role in degradation of airway epithelial cells and inducing of lung fibrosis by activating collagen production that is a major point in identification of lung fibrosis. We also showed that Captopril treatment significantly inhibits IL13 expression in the lungs. We believe it reduces meconium-induced lung injury and has a therapeutic effect on histological and biochemical functions of the lungs and possibly pulmonary fibrosis. Captopril treatment significantly reduced the number of neuprophils and macrophages which express IL13 and levels of other inflammatory cytokines after meconium instillation. Selective neutralization of IL13 ameliorated lung injury, airway hyper responsiveness, eosinophil recruitment and mucus overproduction.
INTRODUCTION
Meconium aspiration syndrome (MAS) causes inflammation of airways and an inappropriate immune response with elevated levels of TNF, IL1, IL6 and IL8 inflammatory cytokines expression [1] . Lung disease severity directly correlates with progressive inflammation of the alveoli and airways which induce airway obstruction and cell apoptosis. We studied a meconiuminduced lung injury in isolated perfused rat lungs exposed to anoxia [2] . We also demonstrated that inflammatory response in meconium-instilled lungs [3] resulted in apoptotic cell death [4, 5] . Lung cell response and injury to inflammation is mediated via induction of cytokines. Meconium in the lungs induces multiple cytokine systems expression including TNF, IL1, IL6, IL8, IL10, IL13 and other cytokines. From these IL10 and IL13 are anti-inflammatory cytokine and others proinflammatory cytokines. Proinflammatory cytokines in MAS have been studied extensively. However, the role of anti-inflammatory agents, including IL13, have not been studied. Its role for inducing a lung fibrosis is well known, however, its presence in MAS was not demonstrated before [9] .
In our previous work we demonstrated that apoptotic cell death can be effectively attenuated by treatment with Captopril [6] . We also determined that angiotensin II (ANG II) plays a major role in meconium-induced apoptosis [7] and its inhibitors like Losartan (inhibitor of ANG II-AT1 receptors) dramatically decreases apoptotic cell death [8] . Despite these findings the exact mechanism of meconium-induced lung cell apoptosis remains unclear.
Expression of IL13 receptors has been shown in variety of immune and nonimmune cells including B cells, natural killer cells, monocytes, mast cells, endothelial cells and fibroblasts [10] [11] [12] , but not in T cells [3] . The potent spasmogenic properties of IL13 have identified this molecule as a potential regulator of airway hyper reactivity in asthma and in emphysema [14] . It enhanced lung volumes and contributed to decreased compliance, mucus metaplasia and inflammation. The effect of IL13 is similar to IL4. Both cytokines activate the JAK2 tyrosine-dependent signal transduction pathway [12] . Both are located on human chromosome 5q25-31 [15] induce activation of pulmonary fibroblasts [9] and mononuclear cells and macrophages [16] . Specifically, IL13 induces fibroblast proliferation in the lungs [9, 17] and liver [18] . IL13 enhances generation of other inflammatory cytokines and chemokines (such as TNF and IL6) inhibitors of IL13 or (IL13Ra2), markedly attenuated granuloma development, pulmonary eosinophilia and pulmonary fibrosis.
To induce injury IL13 should bind to its cell surface receptor [19] . By blocking IL13 binding to its receptors cell injury is significantly decreased. It was shown that by blocking the IL13 receptor with IL13PE (IL13 immunotoxin) fibroblast proliferation decreased by about 30% [20] . Expression of IL13 induces significant collagen type 1 and 2 production in fibroblast cell lines demonstrate a higher degree of proliferation [20] . We propose that limiting the exposure of lung cells to IL13 will significantly limit or reduce the degree of lung injury and fibrosis [20] .
MATERIALS AND METHODS
Meconium preparation. 10% meconium preparation and cell death analysis were performed as described by us earlier [5] .
Pretreatment with Captopril. Two week old rabbits were pretreated with 500 mg/L Captopril in their drinking water 48 hrs prior to meconium instillation as described previously [6] .
Pretreatment with Losartan. Another group of rabbits received two days of pretreatment with Losartan (an AT1 receptor binding agent and inhibitor which inhibits production of ANG II and consequently apoptosis) in the rabbit chow targeted to approximate (by food consumption) 5.0 mg/kg/day as described earlier [8] .
Lung lavage. Rabbits were euthanized and lungs were isolated. Lung lavage was obtained from the left lung and the right lung was used for immunohistochemistry. The left lung was cannulated and removed, and right lung was instilled with 10 ml 1 × PBS and lavage was collected immediately. The procedure was repeated 5 times and all lung lavage collections were pooled. Lavage cells were disrupted by freeze-thawing procedure and then where centrifuged at 5000 RPM for 5 min at 4˚C to separate cell debris. Then supernatants were collected and stored at -70˚C. The levels of IL13 were determined immunologically using an ELISA kit (R&D Systems Inc., Minneapolis, MI) according the manufacturers instructions. Lung lavage cell death was counted after staining of cells by ethidium bromide and acrydine orange as described previously [5] .
Lung histology. Rabbits were instilled intratracheally with 10% meconium or normal saline and were sacrificed 8 hrs after instillation. Following anesthesia-induced euthanasia, the right lungs from meconium-instilled rabbits were separated and fully inflated with 4% formalin, dissected, and placed in fresh formalin for 24 hrs. Routine histological techniques were used to paraffin-embed the entire lung, and 2 m sections of whole lung were stained with H&E. Each whole lung from the meconium treatment group was examined for the presence of inflammatory infiltrates and interstitial fibrosis 8 hrs after meconium instillation and graded with a previously described scale [21] . For this purpose, 10% meconium was instilled intratracheally into rabbit pups lungs and then rabbits were sacrificed 8 hrs after instillation.
Immunohistochemistry. Paraffin-embedded whole lung samples were analyzed for immunohistochemical localization of IL13. This procedure was used for the detection of IL13 expression in whole lung samples because of a growing concern that the ELISAs may underestimate IL13 actual levels in the lungs. Two micron sections were dewaxed with xelene, rehydrated in graded concentrations of ethanol, and blocked with normal rabbit serum (Vectastain ABC-AP kit; Vector Laboratories, Burlingame, CA). A solution containing a 1/1 ratio of water to methanol with 3% hydrogen peroxide was added to each slide to be stained for the presence of IL13. Goat anti rabbit IL13 and a control normal goat IgG were diluted in PBS to a final concentration of 2 g/ml. Specific IgG were added to histological sections for 60 min, after which each tissue section was washed thoroughly three times with PBS. A secondary rabbit anti-goat biotinylated antibodies (Vector Laboratories, Burlingame, CA) were also added to each section for 60 min, then each slide was thoroughly washed and to each was added alkaline phosphatase (Vector Laboratories, Burlingame, CA) conjugated to avidin. IL13 cytokine was revealed with an alkaline substrate, 5-bromo-4-chloro-3-indolyphosphate/nitro blue tetazolium. Cover slips were applied to each slide using an aqueous mounting solution. As positive IL13 control we used human LCH tissue. As negative IL13 control-normal skin.
ELISA analysis. Rabbit IgG anti-IL13 monoclonal antibody was coated on a 96 well plate overnight at 4˚C, then serially diluted samples, or serial dilutions of IL13 used as a standard for 1 hr at 37˚C. Detection was performed using a polyclonal biotinylated goat anti-rabbit IL13 antibody from R&D systems (Minneapolis, MN), according their instructions) for 1 hr at 37˚C.
The detailed technique for measurement of IL13 cytokine in 50 l samples was described earlier [22] . Cell samples were prepared from whole lung samples homogenized in 2 ml of PBS immediately before ELISA. Each ELISA was screened to ensure antibody specificity. Recombinant cytokines were used to generate the standard curves for ELISA from which the concentrations present in the samples were calculated. The limit of ELISA detection for each cytokine was consistently more then 50 pg/ml. The cytokine levels in each sample were normalized to total protein levels measured by the Bradford Assay.
PCR analysis. IL13 gene expression was analyzed by a real-time quantitative PCR procedure (Applied Biosystems, Foster City, CA). The cDNAs from lung lavage samples before and at various times after meconium instillation were analyzed for IL13 and GAPDH (an internal control). All primers and probes used were purchased from Applied Biosystems (Foster City, CA). Cytokine gene expression was normalized to GAPDH, and the fold increases in IL13 gene expression was calculated via the comparison of gene expression in all meconiuminstilled lungs with that in lungs instilled by normal saline.
PCR conditions: PCR amplifications were conducted on a robocycler gradient 96 (Stratagene) in a 30 l reaction containing 100 ng of DNA, 10 mM Tris-HCl, pH9, 0.1% Triton X-100, 50 mM KCl, 0.2 mg/ml BSA, 1.5 mM MgCl 2 , 1 M f each primer, 1mM of dNTP and 1.5 U of Taq polymerase (Appligene Biosystems, Foster City, CA). Following the initial denaturation step (94˚C, 5 min), samples were subjected to 35 cycles of PCR consisting of 94˚C for 1 min, annealing temperature for 45 s and 72˚C for 45 s.
The PCR analysis for IL13 was previously described by Graves et al. [42] . A 236-bp PCR fragment of IL13 cytokine was generated with use of the primers 5'-GCA-AATAATGAGCTTTCGAAGTTTCAGTGG-3' and 5'-CTTCCGTGAGGACTGAATGAGACGGTC-3'. To confirm specificity of obtained fragment restriction analysis were done. The NlaIV restriction enzyme analysis of the PCR product obtained from subjects bearing the IL13 must have two bands (210 and 26 bp) on 2% agarose gel. Loading volume including a loading buffer was 20 l per well, same for all samples.
Statistical analysis. The data analyzed by ANOVA followed. The significance of differences between experimental groups was analyzed using Student's unpaired t-test. Values were reported as the mean ± SEM. Differences in mean values were considered significant if p < 0.05.
RESULTS
Changes in IL13 expression after meconium-induced lung fibrosis. We demonstrated by ELISA assays that IL13 protein expression were increased at all times: 2, 4, 8 and 24 hrs after meconium instillation versus saline instillation (Figure 1) . The greatest, about five fold, increase in IL13 protein expression compared to basal level was observed 8 hrs after meconium instillation. For a comparison, the expression of other cytokines in meconium-instilled lungs versus saline-instilled lungs is also presented in the Figure 2 . The meconium-saline ratios of TNF, IL6, and IL8 were increased significantly in meconium-instilled lungs. TNF reached maximum at 2 hrs after meconium instillation and IL13, IL6 and IL8 at 8 hrs after meconium instillation. In contrast, IL10 levels did not change significantly in any of the groups studies.
Dependence of IL13 expression from Captopril pretreatment. In present study we determined whether pretreatment with angiotensin converting enzyme, Captopril, will prevent meconium-induced lung fibrosis. Captopril, similarly to Losartan described below did not change the histological and immunological picture of the lungs (Figures 3, 7 and 8) . Earlier it was demonstrated that Captopril is able to reduce lung cell inflammation, apoptosis [4] and pulmonary fibrosis [24] . Pretreatment of rabbits with Captopril significantly reduced meconium-induced expression of IL13, lung injury, lung apoptosis and fibrosis compared to control rabbits, instilled with normal saline (Figures 3 and 8) . Captopril was also able to inhibit expression of other cytokines studied. Immunohistochemical analysis of IL13 in formalin-fixed whole lung samples from meconium-instilled rabbits showed a marked decrease of IL13 in Captopril treated rabbits.
Description of meconium induced lung injury. Meconium-instilled lungs stained by Hematoxylin and Eosin demonstrated a broken alveoli, accumulation of necrotic cells (right side of the Figure 4) , hemorrhage and damage of bronchoalveolar alveoli. Alveolar walls of the lungs instilled by meconium were thin, damaged and fewer cells were observed compared to controls. The sacules are not lined by cuboidal epithelium with apical nuclei (progenitor alveolar epithelium). Several protuberances or bungles into the air spaces were noted as well. Also, thinner secondary crests and alveoli are evident. Fewer nuclei are evident in the alveolar walls when compared to those of the term controls (Figure 4) . Meconium-damaged lungs were analyzed in comparison with saline instilled lungs, published by us previously [4, 5] .
Effect of Losartan on IL13 expression in MAS.
We further studied an effect of Losartan on IL13 expression. Saline-instilled lungs with or without Losartan pretreatment in immunohistochemical studies did not show Figure 4 . Meconium-induced lung injury. Hematoxylin and Eosin (H&E) staining revealed brocken alveoli, accumulation of necrotic cells, hemorrhage and damage of bronchioles. Alveolar walls of the lungs from meconium-instilled rabbit lungs were thin, damaged and have fewer cells compared to controls (saline-instilled). The saccules are not lined by cuboidal epithelium with apical nuclei (progenitor alveolar epithelium). Several protuberances or bugles into the air spaces were noted as well. Also, thinner secondary crests and alveoli are evident. Fewer nuclei are evident in the alveolar walls when compared to those of the term controls. Original magnification, ×40. Pictures were analyzed side by side in comparison with normal lungs instilled with normal saline and published by us earlier [4, 5] .
Losartan, Saline
No Losartan, Saline (a) (b) Figure 5 . Expression of IL13 in saline-instilled rabbits with or without Losartan pretreatment. This figure presented as a control for IL13 staining in presence (a) and absence (b) of Losartan. Details about Losartan pretreatment described in methods above. Note, in both cases IL13 cytokine is not expressed.
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Copyright © 2011 SciRes. JBiSE 614 staining for IL13 ( Figure 5) . However, in meconiuminstilled lungs IL13 expression increased dramatically with a maximum level observed at 8 hrs after meconium instillation (Figures 1 and 6) . We determined that BAL IL13 levels were less then or equal to 75 pg/ml in meconium-treated lungs compared to 20 pg/ml in saline treated. This expression was markedly attenuated by Losartan. Expression of IL13 was always associated with accumulation of mononuclear cells and macrophages in the lung lavage samples. Specifically, IL13 expression was observed in activated mononuclear cells, airway epithelium cells and fibrotic interstitial areas. 
No IL13 antibodies

Histological evaluation of IL13 cytokine expression in MAS.
Newborn lungs instilled with normal saline did not show any histological abnormalities in presence of Losartan ( Figure 5) or Captopril (Figure 7) . However, lungs instilled by meconium demonstrate strong expression of IL13 (Figures 4, 6 and 8) , followed by inflammatory cell infiltration and lung fibrosis in rabbits. Histological changes were morphologically obvious. We detected enlargement of alevoli with loss of the orderly appearance. IL13-induced lung fibrosis was accompanied with severe damage of bronchial and less damage of vascular or alveolar epithelium. Maximum damage was observed at 8 hrs after meconium instillation and remained at the same level up to 24 hrs after instillation. Inflammation consisted of increased number of macrophages, lymphocytes and eosinophils in peribronchial and parenchyma tissues as well as lavage fluid.
PCR analysis of IL13 cytokine. Figure 9 shows an PCR analysis for IL13 DNA in tracheal aspirates obtained from newborn rabbits instilled intratracheally with: The PCR analysis in 2% agarose revealed 236 bp IL13 fragments. The NlaIV restriction analysis of the PCR product obtained from subjects bearing the IL13 gives two bands (210 and 26 bp) on same 2% agarose gel (Figure 9, lane 7) . This analysis confirmed specificity of IL13 PCR fragment obtained. The purification procedure and PCR analysis was controlled by levels of GAPDH in same samples. Results show, that Captopril or Losartan has virtually no effect on IL13 expression in lung lavage of rabbits after saline instillation. However, meconium-induced rabbit lung demonstrate a dramatic expression of IL13. Densitometry data showed that pretreatment by Captopril inhibits meconium-induced IL13 expression by 85% compared to 65% inhibition by Losartan (Figure 9, lanes 5, 6) . These data showed that Losartan and especially Captopril are effective inhibitors of IL13 cytokine expression and meconium-induced lung fibrosis.
DISCUSSION
It has been previously shown that IL13, but not IL4 was a major profibrotic mediator in bleomycin-induced fibrotic mice [16] . However expression of IL13 in meconium-instilled lungs was not previously reported. IL13 was produced more strongly in the lung, then in the heart, liver, stomach, kidney, pancreas or testis [25] . The present study addressed two major aims: 1) to examine the expression of IL13 during development of meconiuminduced lung injury and fibrosis. 2) To determine the role of IL13 responsive cells in the pulmonary fibrotic response via targeting these cells by Captopril. It was noted that IL13 has potential activating effects on monocytes and macrophages that include enhanced IL6, TGF, chemokines and chemokines receptors expression [26] . Resident macrophage and recruited monocyte activation is a well-described feature of clinical pulmonary fibrosis [27, 28] and these cells contribute to the pathogenesis of pulmonary fibrosis due to bleomycin [29] . IL13 is a potent inducer of collagen production in vivo in the lung [30] . It also was previously shown that IL13 inhibits proteases and degrades the extra cellular matrix [31] . This effect of IL13 is similar to the effect of protease inhibitors, serpins. A balance of pro-and antifibrotic proteases is critical because excess protease or anti-protease activity has been associated with excessive pulmonary fibrosis induced by the anti-neoplastic drug bleomycin. This imbalance in protease regulation is regulated by the pulmonary fibrotic factors and events. Expression of IL13 is dependent on the activity of extra cellular proteases [30] . Usually an increase of proteinase activities would prevent or reverse the increased deposition of extra cellular matrix and would be associated with lung diseases and inflammation [31] .
Recently, IL13 has been identified as a potent regulator of bronchoconstriction in mouse models of asthma [14] . This cytokine is primarily secreted from T cells but it is also expressed by mast cells, macrophages, eosinophils and NK cells [33] [34] [35] . IL13 shares about 30% homology with IL4 and has similar biological functions. IL13 is a central regulator of mucus production in the lungs.
We found increased IL13 protein in areas of active fibrosis in newborn lung histological sections and its expression peaked 8 hrs after meconium instillation. Immunohistochemistry revealed that IL13 was concentrated preferentially in macrophages and mononuclear cells near or in areas of active fibrosis. This finding was consistent with previous observations that IL13 may be expressed by normal human alveolar macrophages as part of a homeostatic control process, but its production was increased in the presence of fibrotic lung disease [36] . IL13 has significant impact on the synthetic and proliferative properties of granuloma fibroblasts, but not normal fibroblasts, and the IL13-responsiveness of granuloma fibroblasts renders them targets of IL13-based immunotoxin therapy. It also was shown that IL13 is a potent inducer of cysteine proteases production in the lungs [25] . Protease synthesis increases in a dose dependent manner by IL13. As proteases are major destructive agents in the cells. They correlate with increased IL13 expression in meconium-induced lung injury. The levels of mRNA-encoding cysteine proteases have been measured. IL13 also cause an impressive increase in the levels of mRNA encoding cathepsins B, H, K, S and others [25] . Cysteine protease inhibitors such as E-64 or leupeptin decreased expression of IL13. Lung emphysema causes dramatic increases of IL13 expression and promotes an increase in lung volume and lung alveolar size. It also induces significant histological and morphologic changes. These studies demonstrated that cysteine proteases play a major role in the pathogenesis of IL13-induced lung inflammation and later fibrosis. IL13 induced lung enlargement was significantly decreased by treatment with cysteine protease inhibitors and antagonists [25] . To understand the balance of proteases and antiproteases in the lungs the levels of IL13 must be examined. We believe, that IL13 is an important regulator of pulmonary protease and antiprotease balance that can contribute to the patophysiology of MAS.
Previous studies suggest that the deregulation of apop-totic pathways may explain the pathogenesis of a number of chronic lung diseases [37] . Our interest in IL13 induction of genes responsible for an apoptotic process in the lung stemmed from preliminary studies, where IL13-induced cytotoxicity in tumor cell lines via its ability to up-regulate proapoptotic and down-regulate antiapoptotic factors in these cells [15] . The TNF related proapoptotic factor TRAIL is a potent inducer of fibroblast apoptosis by induction of a number of proapoptotic factors, especially caspase 9 [38] . IL13 is a pleiotropic cytokine with remarkable effects in the newborn lungs. Overexpression of IL13 causes macrophage, lymphocyte and eosinophILrich pulmonary inflammatory response, mucus metaplasia, crystal deposition, subepitelial fibrosis and alveolar enlargement in MAS. The majority of alveoli are formed by developmental process that occurred at birth and we not sure whether alveolar enlargement is due to alterations in alveolar development or due to the destruction of already normally formed alveoli. However, results with adult rabbits also showed alveolar enlargement. These results demonstrate, that alveolar enlargement is a short term lung response to injury but lung fibrosis require more extensive periods of time. We believe that injuries effect of IL13 involved a production of ANG II and ACE inhibitor Captopril should significantly decrease its injuries effect. Captopril inhibits conversion of ANGEN to ANG II and consequently apoptosis formation. IL13 is also is a strong activator of tissue proteolysis [25] .
Blockage of serine or cysteine proteases has remarkably ameliorated the effects of IL13 induced lung inflammation and apoptosis. The effect of cysteine protease inhibitors, serpins, on IL13 effect was also evaluated. Serpins abrogated the IL13-induced lung inflammatory response [25] . Serpins also were able to significantly reduce IL13 induced increase in lung volume and alveolar size. They reduce IL13 induced lung and lavage cell inflammation.
Our findings demonstrate the impact of IL13 on the alveolar cells, lung injury and potentially on lung fibrosis. The responses of alveolar cells to the expression of IL13 suggest that these cells could be targeted with an anti-IL13 antibody [39] . It is very possible that its antibodies and other inhibitors may be important in preventing a MAS and consequent lung fibrosis.
CONCLUSIONS
We have demonstrated elevated expression of the inflammatory cytokine IL13 in meconium-instilled two week old rabbit pups' lungs. We also showed that pretreatment with Captopril significantly decreased meconium-induced expression of IL13 cytokine as well as meconium-induced lung injury and apoptosis. This finding suggests that the mechanism of IL13 induced lung injury is similar to that caused by TNF, IL6 and IL8 cytokine mechanisms.
